APOE and neurodegenerative disease: We have discussed the complex interactions between evolutionary selection, genetic ancestry, and biomarker outcomes for two loci critical for neurodegenerative disease risk: 17q21.31 and APOE. Increasing representation of non-European individuals in genetic and biomarker studies will lead to an improved understanding of disease pathogenesis, and ultimately the development of therapeutic strategies that will be effective across diverse populations.